MedPath

Succinylcholine

Generic Name
Succinylcholine
Brand Names
Anectine, Quelicin
Drug Type
Small Molecule
Chemical Formula
C14H30N2O4
CAS Number
306-40-1
Unique Ingredient Identifier
J2R869A8YF
Background

Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter acetylcholine (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.

Indication

Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Therapies
Tracheal Intubation

Muscle Relaxation for Short Procedures

Not Applicable
Completed
Conditions
Intubating Conditions
Fasciculations
Postoperative Myalgia
Patient Satisfaction
Sore Throat
Interventions
Drug: Rocuronium/Sugammadex
First Posted Date
2013-07-18
Last Posted Date
2013-07-18
Lead Sponsor
Dr. Horst Schmidt Klinik GmbH
Target Recruit Count
105
Registration Number
NCT01902641
Locations
🇩🇪

Dr. Horst Schmidt Kliniken, Wiesbaden, Germany

Modern Myorelaxation Procedure and Reversal of Neuromuscular Blockade With General Anesthesia for Caesarean Section

Phase 4
Completed
Conditions
Caesarean Section
Pregnancy
Interventions
First Posted Date
2012-10-31
Last Posted Date
2016-07-26
Lead Sponsor
Brno University Hospital
Target Recruit Count
500
Registration Number
NCT01718236
Locations
🇨🇿

Faculty hospital Brno, Brno, Jihomoravský Kraj, Czech Republic

🇨🇿

Faculty Hospital Olomouc, Olomouc, Olomoucký kraj, Czech Republic

Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia

Phase 4
Terminated
Conditions
Anesthesia
Interventions
First Posted Date
2012-04-18
Last Posted Date
2016-11-03
Lead Sponsor
Hopital Foch
Target Recruit Count
6
Registration Number
NCT01579864
Locations
🇫🇷

Hopital Foch, Suresnes, Ile de France, France

Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study

Phase 2
Completed
Conditions
Intubation Conditions
Interventions
Drug: Magnesium perfusion
Drug: Placebo perfusion
First Posted Date
2012-04-05
Last Posted Date
2015-07-20
Lead Sponsor
University Hospital, Geneva
Target Recruit Count
280
Registration Number
NCT01571908
Locations
🇨🇭

University Hospital of Geneva, Anesthesia Department, Geneva, Canton of Geneva, Switzerland

🇨🇭

Division of Anaesthesiology, University Hospital of Lausanne (CHUV), Lausanne, Vaud, Switzerland

Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)

Not Applicable
Completed
Conditions
Neuromuscular Blockade
ECT
Interventions
First Posted Date
2011-09-28
Last Posted Date
2015-06-02
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
45
Registration Number
NCT01441960
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Effect of Succinylcholine on Patients Using Statins

Not Applicable
Completed
Conditions
Pain
Interventions
First Posted Date
2009-09-30
Last Posted Date
2016-10-03
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
70
Registration Number
NCT00986583
Locations
🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

Rapid Sequence Intubation With Rocuronium-Sugammadex Compared With Succinylcholine

Phase 4
Completed
Conditions
Rapid Sequence Intubation
Interventions
Drug: Rocuronium-Sugammadex
First Posted Date
2009-08-06
Last Posted Date
2011-03-02
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
61
Registration Number
NCT00953550
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

🇩🇰

Herlev Hospital, Herlev, Denmark

Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Participants Undergoing Short Surgical Procedures (19.4.319)(P05700 AM2)(COMPLETED)

Phase 3
Completed
Conditions
Neuromuscular Blockade
Interventions
First Posted Date
2008-09-11
Last Posted Date
2015-06-30
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
161
Registration Number
NCT00751179

Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)

Phase 3
Completed
Conditions
Anesthesia, General
Interventions
First Posted Date
2007-05-16
Last Posted Date
2019-04-11
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
115
Registration Number
NCT00474253

Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care

Phase 4
Completed
Conditions
Intubation
Interventions
First Posted Date
2006-07-21
Last Posted Date
2011-12-15
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
420
Registration Number
NCT00355368
Locations
🇨🇭

Department of Medical Intensive Care; University of Basel, Basel, BS, Switzerland

© Copyright 2025. All Rights Reserved by MedPath